These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16985068)

  • 21. Farnesylthiosalicylic acid induces caspase activation and apoptosis in glioblastoma cells.
    Amos S; Redpath GT; Polar G; McPheson R; Schiff D; Hussaini IM
    Cell Death Differ; 2006 Apr; 13(4):642-51. PubMed ID: 16239932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ras inhibitor S-trans, trans-farnesylthiosalicylic acid enhances spatial memory and hippocampal long-term potentiation via up-regulation of NMDA receptor.
    Wang Y; Chen T; Yuan Z; Zhang Y; Zhang B; Zhao L; Chen L
    Neuropharmacology; 2018 Sep; 139():257-267. PubMed ID: 29578035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis.
    Karussis D; Abramsky O; Grigoriadis N; Chapman J; Mizrachi-Koll R; Niv H; Kloog Y
    J Neuroimmunol; 2001 Nov; 120(1-2):1-9. PubMed ID: 11694313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
    Reif S; Weis B; Aeed H; Gana-Weis M; Zaidel L; Avni Y; Romanelli RG; Pinzani M; Kloog Y; Bruck R
    J Hepatol; 1999 Dec; 31(6):1053-61. PubMed ID: 10604579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
    Santen RJ; Lynch AR; Neal LR; McPherson RA; Yue W
    Anticancer Drugs; 2006 Jan; 17(1):33-40. PubMed ID: 16317288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer.
    Kaneko R; Tsuji N; Asanuma K; Tanabe H; Kobayashi D; Watanabe N
    J Biol Chem; 2007 Jul; 282(27):19273-81. PubMed ID: 17472962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
    Aizman E; Mor A; Levy A; George J; Kloog Y
    Oncotarget; 2012 Feb; 3(2):144-57. PubMed ID: 22323550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy.
    Biran A; Brownstein M; Haklai R; Kloog Y
    Int J Cancer; 2011 Feb; 128(3):691-701. PubMed ID: 20473860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stringent structural requirements for anti-Ras activity of S-prenyl analogues.
    Aharonson Z; Gana-Weisz M; Varsano T; Haklai R; Marciano D; Kloog Y
    Biochim Biophys Acta; 1998 Feb; 1406(1):40-50. PubMed ID: 9545527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation.
    Gana-Weisz M; Haklai R; Marciano D; Egozi Y; Ben-Baruch G; Kloog Y
    Biochem Biophys Res Commun; 1997 Oct; 239(3):900-4. PubMed ID: 9367867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis.
    Clarke HC; Kocher HM; Khwaja A; Kloog Y; Cook HT; Hendry BM
    J Am Soc Nephrol; 2003 Apr; 14(4):848-54. PubMed ID: 12660318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Ras antagonist blocks human melanoma growth.
    Jansen B; Schlagbauer-Wadl H; Kahr H; Heere-Ress E; Mayer BX; Eichler H; Pehamberger H; Gana-Weisz M; Ben-David E; Kloog Y; Wolff K
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14019-24. PubMed ID: 10570191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.
    Stärkel P; Charette N; Borbath I; Schneider-Merck T; De Saeger C; Abarca J; Leclercq I; Horsmans Y
    Mol Carcinog; 2012 Oct; 51(10):816-25. PubMed ID: 21882255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
    Yang L; Cao Z; Yan H; Wood WC
    Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ras-mediated up-regulation of survivin expression in cytokine-dependent murine pro-B lymphocytic cells.
    Shinjyo T; Kurosawa H; Miyagi J; Ohama K; Masuda M; Nagasaki A; Matsui H; Inaba T; Furukawa Y; Takasu N
    Tohoku J Exp Med; 2008 Sep; 216(1):25-34. PubMed ID: 18719335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth.
    Marciano D; Ben-Baruch G; Marom M; Egozi Y; Haklai R; Kloog Y
    J Med Chem; 1995 Apr; 38(8):1267-72. PubMed ID: 7731012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin].
    Dai DJ; Lu CD; Guo JM; Zhang J
    Ai Zheng; 2005 Aug; 24(8):951-7. PubMed ID: 16086872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells.
    Scheper MA; Shirtliff ME; Meiller TF; Peters BM; Jabra-Rizk MA
    Neoplasia; 2008 Sep; 10(9):954-63. PubMed ID: 18714396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.